MSH6
≈ 3 min read
Names in other languages
- DeutschMSH6
- EnglishMSH6
- EspañolMSH6
- FrançaisMSH6
- ItalianoMSH6
- NederlandsMSH6
- PortuguêsMSH6
- srnMSH6
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
MSH6 or mutS homolog 6 is a gene that codes for DNA mismatch repair protein Msh6 in the budding yeast Saccharomyces cerevisiae. It is the homologue of the human "G/T binding protein," (GTBP) also called p160 or hMSH6 (human MSH6). The MSH6 protein is a member of the Mutator S (MutS) family of proteins that are involved in DNA damage repair. Defects in hMSH6 are associated with atypical hereditary nonpolyposis colorectal cancer not fulfilling the Amsterdam criteria for HNPCC. hMSH6 mutations have also been linked to endometrial cancer and the development of endometrial carcinomas.
MSH6 or mutS homolog 6 is a gene that codes for DNA mismatch repair protein Msh6 in the budding yeast Saccharomyces cerevisiae. It is the homologue of the human "G/T binding protein," (GTBP) also called p160 or hMSH6 (human MSH6). The MSH6 protein is a member of the Mutator S (MutS) family of proteins that are involved in DNA damage repair. Defects in hMSH6 are associated with atypical hereditary nonpolyposis colorectal cancer not fulfilling the Amsterdam criteria for HNPCC. hMSH6 mutations have also been linked to endometrial cancer and the development of endometrial carcinomas.
Importance of mismatch repair
Mismatches commonly occur as a result of DNA replication errors, genetic recombination, or other chemical and physical factors. Recognizing those mismatches and repairing them is extremely important for cells, because failure to do so results in microsatellite instability, an elevated spontaneous mutation rate (mutator phenotype), and susceptibility to HNPCC. hMSH6 combines with hMSH2 to form the active protein complex, hMutS alpha, also called hMSH2-hMSH6.
Epigenetic control of MSH6 in cancer
Two microRNAs, miR21 and miR-155, target the DNA mismatch repair (MMR) genes hMSH6 and hMSH2, to cause reduced expression of their proteins. If one or the other of these two microRNAs is over-expressed, hMSH2 and hMSH6 proteins are under-expressed, resulting in reduced DNA mismatch repair and increased microsatellite instability. One of these microRNAs, miR21, is regulated by the epigenetic methylation state of the CpG islands in one or the other of its two promoter regions. Hypomethylation of its promoter region is associated with increased expression of an miRNA. High expression of a microRNA causes repression of its target genes (see microRNA silencing of genes). In 66% to 90% of colon cancers, miR-21 was over-expressed, and generally the measured level of hMSH2 was decreased (and hMSH6 is unstable without hMSH2 ). The other microRNA, miR-155, is regulated both by epigenetic methylation of the CpG islands in its promoter region and by epigenetic acetylation of histones H2A and H3 at the miR-155 promoter (where acetylation increases transcription). Measured by two different methods, miR-155 was over-expressed in sporadic colorectal cancers by either 22% or 50%. When miR-155 was elevated, hMSH2 was under-expressed in 44% to 67% of the same tissues (and hMSH6 is likely under-expressed as well, and also unstable in the absence of hMSH2). FAQs on HNPCC from the National Institute of Health GeneReviews/NCBI/NIH/UW entry on Lynch syndrome
Text derived from https://en.wikipedia.org/w/index.php?oldid=1310524566 under CC BY-SA 4.0; modifications have been made.